BMA vs BSAC Stock Comparison
BSAC currently leads BMA in this stock comparison, with AIQ scores of 49 vs 47. The clearest difference is momentum, while BMA has the stronger value profile.
What is the main difference between BMA and BSAC?
BSAC leads the current stock comparison as Banco Santander-Chile, with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Banco Macro S.A. vs Banco Santander-Chile
BSAC leads
BSAC leads by 2 AIQ points, primarily on Momentum and Risk Resilience.
Fragile: 3 of 5 evidence groups support BSAC, and its current signal state is conflicted.
Banco Macro S.A.
Banco Santander-Chile
The Algovestiq AIQ Score currently favors BSAC over BMA, 49 versus 47 as of Nov 15, 2026. BSAC's advantage is driven primarily by stronger momentum and risk resilience, while BMA holds the stronger value profile. BSAC also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor BSAC today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. BSAC lead: Stable — the AIQ differential has held near 2 points over 30 sessions.
Compare Banco Macro S.A. and Banco Santander-Chile across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BMA and BSAC against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value61 vs 15BMA +46
- Momentum18 vs 53BSAC +35
- Risk Resilience49 vs 76BSAC +27
- Quality71 vs 55BMA +16
3 of 5 evidence groups favor BSAC. BSAC’s edge is concentrated in momentum and risk resilience; BMA keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value -3, not enough on its own to move the overall score.
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-11.2%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
Largest factor move: Momentum +2, not enough on its own to move the overall score.
New signals
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.8%)
- RSI Midline Reclaim — bullish, momentum, short horizon
BSAC's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — BMA and BSAC both carry a full feed there.
The central trade-off
BSAC (Banco Santander-Chile): the stronger current systematic profile, led by momentum and risk resilience.
BMA (Banco Macro S.A.): the counter-case, on value, quality, valuation — but at materially higher volatility, 40.4% against 28.3%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BSACBSAC on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BMABMA on combined revenue and EPS growth.
Value
BMABMA on the peer-relative Value factor, by 46 points.
Momentum
BSACBSAC on the Momentum factor, by 35 points.
Lower downside
BSACBSAC on Risk Resilience, by 27 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BMA | BSAC | Note |
|---|---|---|---|
| Implied upside to target | +60% | — | Level |
| Target dispersion | 0% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 9 | 12 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor BSAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 47 vs 49 |
| Fundamentals | BSACon balance | revenue growth -23% vs -56.2%; EPS growth 45.6% vs -37.9%; TTM ROE 3.3% vs 4.8%; gross margin 56.9% vs 61.2%; operating margin 10.5% vs 29.8% — BSAC takes 3 of 5 decided legs, not all of them |
| Valuation | BMA | Value 61 vs 15 |
| Technicals | BSAC | Price vs 50-day -14.6% vs -1.8%; vs 200-day -27.7% vs -2.5% |
| Risk Resilience | BSAC | Risk Resilience 49 vs 76 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BMA and BSAC and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BSAC.
How the comparison changed
120 daily snapshots · May 27 – Nov 13BSAC lead: Stable — the AIQ differential has held near 2 points over 30 sessions.
- Today
- BSAC +2
- 47 vs 49
- 7 sessions ago
- BSAC +3
- 46 vs 49
- 30 sessions ago
- BSAC +3
- 45 vs 48
- 90 sessions ago
- BMA +1
- 49 vs 48
The lead changed hands 6 times in this window, most recently on Nov 2 when BSAC moved ahead of BMA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 3 bearish / 2 neutral, conflicted
Only BMA
- 52-Week Low Proximity — bearish, risk_regime, long horizon (0.8%)
- ADX Trend Strengthening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.10%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
4 bullish / 2 bearish / 2 neutral, conflicted
Only BSAC
- Bollinger Band Squeeze — neutral, volatility, short horizon (7.8%)
- ADX Trend Weakening — neutral, trend, medium horizon
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-15.5%)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- RSI Midline Reclaim — bullish, momentum, short horizon
Both carry 3 more signals that do not separate them: Death Cross Active, Downtrend Structure Active, OBV Bullish Divergence.
BSAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +2.95%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.44%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BMA closes the Momentum gap — currently 35 points behind, the largest single contributor to BSAC's edge.
- 2BMA's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3BSAC's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BSAC leads on balance| Metric | BMA | BSAC |
|---|---|---|
| Revenue growth (YoY) | -23% | -56.2% |
| EPS growth (YoY) | 45.6% | -37.9% |
| Gross margin | 56.9% | 61.2% |
| Operating margin | 10.5% | 29.8% |
| Return on equity (TTM) | 3.3% | 4.8% |
| Debt to equity | 0.27 | 3.51 |
Performance
BSAC leads 6 of 6 windows| Metric | BMA | BSAC |
|---|---|---|
| 1 week (5 sessions) | -1.6% | 0.3% |
| 1 month (20 sessions) | -11.2% | -0.8% |
| 3 months (63 sessions) | -27.9% | -6.2% |
| 6 months (126 sessions) | -19.7% | 7.5% |
| Year to date | -36.9% | 4.2% |
| 1 year (252 sessions) | -34.1% | 6.5% |
Technicals
BSAC has the stronger structure| Metric | BMA | BSAC |
|---|---|---|
| RSI (14) | 35.2 | 50.4 |
| ADX (14) | 34.4 | 19.6 |
| Price vs 50-day | -14.6% | -1.8% |
| Price vs 200-day | -27.7% | -2.5% |
| Volatility (1M, annualized) | 40.4% | 28.3% |
Risk
BSAC is the more resilient| Metric | BMA | BSAC |
|---|---|---|
| Beta | 1.65 | 1.05 |
| Sharpe ratio | -0.58 | 0.33 |
| Sortino ratio | -0.89 | 0.47 |
| Max drawdown | -47.2% | -20.5% |
| Current drawdown | -45.7% | -13.4% |
| Annualized volatility | 50.6% | 29.2% |
| Value at risk (95%) | -4.6% | -3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BMA or BSAC?
On the Algovestiq AIQ Score, BSAC is the stronger of the two as of Nov 15, 2026, scoring 49 against BMA's 47. The edge comes from momentum and risk resilience. BMA is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BMA or BSAC the better buy right now?
BSAC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.
Why does the AIQ Score favor BSAC over BMA?
The composite weights Quality, Value, Momentum and Risk Resilience. BMA leads Value by 46 points; BSAC leads Momentum by 35 points; BSAC leads Risk Resilience by 27 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BMA or BSAC?
Analyst price targets imply +60% upside for BMA and not covered for BSAC. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BMA or BSAC?
BMA is the better-valued of the two on the peer-relative Value factor. BMA on the peer-relative Value factor, by 46 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BMA or BSAC?
BMA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BMA or BSAC?
BSAC on the Momentum factor, by 35 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BMA or BSAC?
BSAC is the more resilient of the two, so the other name carries the higher downside risk. BSAC on Risk Resilience, by 27 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BMA more profitable than BSAC?
BSAC leads on the comparable margin measures — gross margin 56.9% vs 61.2%; operating margin 10.5% vs 29.8%; ttm roe 3.3% vs 4.8%.
Is BSAC's lead over BMA getting stronger or weaker?
BSAC lead: Stable — the AIQ differential has held near 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 6 times in that window, most recently on 2026-11-02, when BSAC moved ahead of BMA.
What would change the BMA vs BSAC verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BMA closes the Momentum gap — currently 35 points behind, the largest single contributor to BSAC's edge; BMA's Death Cross Active resolves — a bearish trend rule currently active against it; BSAC's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about BMA and BSAC?
BMA: 2 bullish / 3 bearish / 2 neutral, conflicted. BSAC: 4 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BMA is Death Cross Active (bearish, long horizon). On BSAC it is Death Cross Active (bearish, long horizon).
Compare BMA and BSAC with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.